Frontiers in Cell and Developmental Biology · Nov 17, 2026
Hyperbaric oxygen treatment improves oocyte and pre-implanted embryo quality in aged mouse
By Weimin Yang, Xiaoyuan Jin, Zhongyan Guan et al.
Ovarian aging is one of the initial signs of systemic aging and is marked by poor quality of oocytes and pre-implanted embryos. Hyperbaric oxygen therapy (HBOT) is a well-established treatment modality for being aging and age-related diseases. In this study, we aimed to investigate the effects of HBOT on the quality of oocytes from naturally aged mice. We found HBOT could increase the FSH and AMH serum levels in aged mouse. Moreover, HBOT not only increases ovulation of aged oocytes but also enhances their meiotic competency by maintaining the normal spindle/chromosome structure and improving mitochondrial distribution and membrane potential. HBOT also increase the fertilization ability and early embryonic development of aged oocytes. Mechanistically, we found HBOT improved the ZGA progress, rescued mitochondrial membrane potential and H3K4me3, H3K27me3 levels in 2 cell embryos from aged oocytes. The total cell and NANOG positive cell number of blastocysts from aged oocytes were increased after HBOT treatment by increasing NANOG and POU5F1 levels. Altogether, our findings suggest that HBOT is a feasible approach to ameliorate oocyte quality in aged mice. Future work is needed to test whether HBOT can contribute to the improvement of reproductive outcome of aged women and assisted reproductive technology.